|
Volumn 142, Issue 6, 2008, Pages 992-995
|
Clinical imatinib mesylate treatment induces early normalisation of aberrant neutrophil leukotriene C4 synthase expression and activity in chronic myeloid leukaemia
|
Author keywords
Chronic myeloid leukaemia; Imatinib mesylate; Leukotriene C4 synthase; Neutrophil; Philadelphia chromosome
|
Indexed keywords
ARABINOSIDE;
BCR ABL PROTEIN;
CREATININE;
IMATINIB;
INTERFERON;
LEUKOTRIENE C4 SYNTHASE;
BONE MARROW CELL;
CHRONIC MYELOID LEUKEMIA;
CONTROLLED STUDY;
CREATININE URINE LEVEL;
DRUG EFFECT;
DRUG TREATMENT FAILURE;
ENZYME IMMUNOASSAY;
ENZYME SYNTHESIS;
GRANULOCYTE;
HUMAN;
HUMAN CELL;
IMMUNOBLOTTING;
IN VIVO STUDY;
LETTER;
NEUTROPHIL;
PHARMACOGENETICS;
PHILADELPHIA 1 CHROMOSOME;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
TREATMENT DURATION;
TREATMENT RESPONSE;
UPREGULATION;
URINARY EXCRETION;
ANTINEOPLASTIC AGENTS;
GLUTATHIONE TRANSFERASE;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
PIPERAZINES;
PYRIMIDINES;
|
EID: 50049121066
PISSN: 00071048
EISSN: 13652141
Source Type: Journal
DOI: 10.1111/j.1365-2141.2008.07283.x Document Type: Letter |
Times cited : (8)
|
References (5)
|